Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Serum amyloid type A may be a predictor of restenosis
Arnon Blum
, Giora Kaplan
, Nurit Vardinon
, Israel Yust
, Michael Burke
, Shlomo Laniado
, Hylton Miller
Tel Aviv Sourasky Medical Center
Ministry of Health, Israel
Research output
:
Contribution to journal
›
Article
›
peer-review
21
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serum amyloid type A may be a predictor of restenosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Serum Amyloid A
100%
Predictors of Restenosis
100%
Angioplasty
42%
Percutaneous Transluminal Coronary Angioplasty
42%
Thallium
28%
Restenosis
28%
Stable Angina
28%
Perfusion Imaging
28%
High Sensitivity
14%
University-affiliated
14%
High Specificity
14%
Angina Pectoris
14%
Relative Risk
14%
Prospective Case Series
14%
Coronary Angiography
14%
C-reactive Protein
14%
Clinical Prognosis
14%
ELISA Method
14%
Acute Phase Proteins
14%
Coronary Lesions
14%
P100
14%
β-Class
14%
Stress Perfusion
14%
Post-angioplasty Restenosis
14%
Tertiary Medical Center
14%
Protein Amyloid
14%
Nursing and Health Professions
Restenosis
100%
Amyloid Protein
100%
Transluminal Coronary Angioplasty
42%
Angioplasty
42%
Perfusion
28%
Thallium
28%
Syndrome
14%
Enzyme Linked Immunosorbent Assay
14%
Coronary Angiography
14%
Stable Angina Pectoris
14%
Unstable Angina Pectoris
14%
Sensitivity and Specificity
14%
C Reactive Protein
14%
Angina Pectoris
14%
Sulfanilamide
14%
Acute Phase Protein
14%
Medicine and Dentistry
Restenosis
100%
Amyloid Protein
100%
Angioplasty
42%
Transluminal Coronary Angioplasty
42%
Thallium
28%
Sensitivity and Specificity
14%
Coronary Angiography
14%
Unstable Angina Pectoris
14%
C Reactive Protein
14%
Angina Pectoris
14%
Stable Angina Pectoris
14%
Enzyme Linked Immunosorbent Assay
14%
Acute Phase Protein
14%
Sulfanilamide
14%